Semglee
Insulin glargine-yfgn · Biocon Biologics Inc.
PRESCRIPTION ONLY (USA)Semglee ingredients
| Active ingredient | Strength |
|---|---|
| Insulin Glargine | 100 [iU]/mL |
What Semglee is used for
Semglee is a specialist medicine (insulin analog). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Semglee
- Generic name
- Insulin glargine-yfgn
- Made by
- Biocon Biologics Inc.
- Forms
- Injection, Solution
- Given
- Subcutaneous
- Drug class
- Insulin Analog
- FDA approval
- Biologic licence (BLA) BLA761201
- On the US market since
- 2023
Official information
- Semglee prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Insulin glargine-yfgn)
In India
- Insulin glargine: 16 brands in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Semglee?
Semglee (Insulin glargine-yfgn) is a specialist medicine made by Biocon Biologics Inc., approved by the US FDA.
What are the ingredients of Semglee?
Semglee contains Insulin Glargine (100 [iU]/mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA